Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Pecci

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
European Journal of Medical Genetics|July 7, 2010
A G to C transversion at the last nucleotide of exon 25 of the MYH9 gene results in a missense mutation rather than in a splicing defectSilvia Vettore, Daniela De Rocco, Bernhard Gerber, et al.
Human Molecular Genetics|September 16, 2005
Pathogenetic mechanisms of hematological abnormalities of patients with MYH9 mutationsAlessandro Pecci, Ilaria Canobbio, Alessandra Balduini, et al.
British Journal of Haematology|March 29, 2002
Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disordersAlessandro Pecci, Patrizia Noris, Rosangela Invernizzi, et al.
Journal of Pediatric Hematology/Oncology|May 26, 2012
MYH9-related disorders: report on a patient of Greek origin presenting with macroscopic hematuria and presenile cataract, caused by an R1165C mutationMarina Economou, Spyros P Batzios, Alessandro Pecci, et al.
Thrombosis and Haemostasis|March 10, 2006
Autosomal dominant thrombocytopenias with reduced expression of glycoprotein IaPatrizia Noris, Gianni F Guidetti, Valeria Conti, et al.
American Journal of Hematology|March 28, 2019
MYH9-related disease mutations cause abnormal red blood cell morphology through increased myosin-actin binding at the membraneAlyson S Smith, Kasturi Pal, Roberta B Nowak, et al.
Infection|February 15, 2025
Microbiological diversity among patients with Lemierre syndrome and clinical implications: an individual patient-level analysisMaurus Frehner, Riccardo M Fumagalli, Silvio D Brugger, et al.
Blood|September 17, 2010
Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutationsAlessandro Pecci, Paolo Gresele, Catherine Klersy, et al.
British Journal of Haematology|February 12, 2004
Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasiaGiovanni Barosi, Vittorio Rosti, Margherita Massa, et al.
Hamostaseologie|March 7, 2022
Cardiac and Cerebral Arterial Complications of Lemierre Syndrome: Results from a Systematic Review and Individual Patient Data Meta-analysisWilliam Pleming, Stefano Barco, Davide Voci, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
European Journal of Medical Genetics|July 7, 2010
A G to C transversion at the last nucleotide of exon 25 of the MYH9 gene results in a missense mutation rather than in a splicing defectSilvia Vettore, Daniela De Rocco, Bernhard Gerber, et al.
Human Molecular Genetics|September 16, 2005
Pathogenetic mechanisms of hematological abnormalities of patients with MYH9 mutationsAlessandro Pecci, Ilaria Canobbio, Alessandra Balduini, et al.
British Journal of Haematology|March 29, 2002
Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disordersAlessandro Pecci, Patrizia Noris, Rosangela Invernizzi, et al.
Journal of Pediatric Hematology/Oncology|May 26, 2012
MYH9-related disorders: report on a patient of Greek origin presenting with macroscopic hematuria and presenile cataract, caused by an R1165C mutationMarina Economou, Spyros P Batzios, Alessandro Pecci, et al.
Thrombosis and Haemostasis|March 10, 2006
Autosomal dominant thrombocytopenias with reduced expression of glycoprotein IaPatrizia Noris, Gianni F Guidetti, Valeria Conti, et al.
American Journal of Hematology|March 28, 2019
MYH9-related disease mutations cause abnormal red blood cell morphology through increased myosin-actin binding at the membraneAlyson S Smith, Kasturi Pal, Roberta B Nowak, et al.
Infection|February 15, 2025
Microbiological diversity among patients with Lemierre syndrome and clinical implications: an individual patient-level analysisMaurus Frehner, Riccardo M Fumagalli, Silvio D Brugger, et al.
Blood|September 17, 2010
Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutationsAlessandro Pecci, Paolo Gresele, Catherine Klersy, et al.
British Journal of Haematology|February 12, 2004
Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasiaGiovanni Barosi, Vittorio Rosti, Margherita Massa, et al.
Hamostaseologie|March 7, 2022
Cardiac and Cerebral Arterial Complications of Lemierre Syndrome: Results from a Systematic Review and Individual Patient Data Meta-analysisWilliam Pleming, Stefano Barco, Davide Voci, et al.
Pageof 13